🗂️ Navigation

Clinical Ink eConsent

The Premier eSource & Patient Engagement Platform.

Visit Website →

Overview

Clinical Ink's eConsent is a component of their Lunexis platform, which is focused on direct data capture (DDC) and patient engagement. The solution is designed to be highly patient-centric, using multimedia to improve understanding. It is built for complex clinical trials and integrates with other patient-facing solutions like ePRO and telehealth to create a comprehensive patient experience.

✨ Key Features

  • Patient-centric design
  • Multimedia support
  • Integration with eSource (DDC) and ePRO
  • Telehealth visit integration
  • Remote and on-site consenting

🎯 Key Differentiators

  • Pioneer and leader in eSource/Direct Data Capture (DDC)
  • Unified platform for all patient-facing activities
  • Deep therapeutic expertise

Unique Value: Provides a single, unified platform for all patient interactions in a trial, from consent to outcome assessments, creating a seamless experience and eliminating redundant data entry.

🎯 Use Cases (3)

Complex therapeutic areas (e.g., CNS, immunology) Decentralized and hybrid trials Studies focused on patient experience

✅ Best For

  • Conducting all patient-facing activities, from consent to data capture, on a single device

💡 Check With Vendor

Verify these considerations match your specific requirements:

  • Simple trials that do not require advanced patient engagement or eSource capabilities

🏆 Alternatives

Signant Health Medidata TrialKit

Offers a more integrated and comprehensive patient engagement suite than platforms where eConsent, ePRO, and eSource are separate, loosely integrated modules.

💻 Platforms

Web iOS Android

✅ Offline Mode Available

🔌 Integrations

EDC systems

🛟 Support Options

  • ✓ Email Support
  • ✓ Phone Support
  • ✓ Dedicated Support (Enterprise tier)

🔒 Compliance & Security

✓ SOC 2 ✓ HIPAA ✓ BAA Available ✓ GDPR ✓ ISO 27001 ✓ SSO ✓ 21 CFR Part 11

💰 Pricing

Contact for pricing
Visit Clinical Ink eConsent Website →